We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues New MAPP on Product Development, Pre-Submission Meetings for ANDAs
FDA Issues New MAPP on Product Development, Pre-Submission Meetings for ANDAs
The FDA has laid out a three-stage process for how the agency will handle product development and pre-submission meetings for ANDAs, in a new Manual of Policies and Procedures (MAPP) released on Tuesday.